Clovis Oncology Free Cash Flow TTM:
-66.44M for Dec. 31, 2012Clovis Oncology Historical Free Cash Flow TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -66.44M |
| Sept. 30, 2012 | -60.45M |
| June 30, 2012 | -55.56M |
| March 31, 2012 | -51.22M |
| Dec. 31, 2011 | -40.27M |
| Sept. 30, 2011 | -45.80M |
| June 30, 2011 | -41.15M |
| March 31, 2011 | -38.10M |
| Dec. 31, 2010 | -34.78M |
About Free Cash Flow (TTM)
CLVS Free Cash Flow TTM Benchmarks
| Companies | |
|---|---|
| Coronado Biosciences | -23.19M |
| Halozyme Therapeutics | -65.74M |
| Infinity Pharmaceuticals | -81.44M |
CLVS Free Cash Flow TTM Rankings
| Overall |
43rd percentile 4483 of 8002 |
| Sector |
16th percentile 571 of 684 in Healthcare |
| Industry |
22nd percentile 193 of 248 in Biotechnology |
CLVS Free Cash Flow TTM Range, Past 5 Years
| Minimum | -66.44M | Dec 2012 |
| Maximum | -34.78M | Dec 2010 |
| Average | -48.20M |
